Mycoplasma genitalium in women with lower genital tract inflammation.
OBJECTIVE
To examine the prevalence of Mycoplasma genitalium in a large number of female patients attending a sexually transmitted infections (STI) clinic and to determine if there is an association with signs or symptoms of lower genital tract inflammation (LGTI).


METHODS
Altogether, 7646 female patients who had symptoms or microscopic signs of LGTI or were perceived to be at high risk of exposure to an STI were tested for both M genitalium and Chlamydia trachomatis. Urethral and cervical smears were examined quantitatively for polymorphic mononuclear leucocytes (PMNLs).


RESULTS
The prevalence of C trachomatis and M genitalium was 10.1% and 4.5%, respectively. We found a clear association between detecting M genitalium in first void urine (FVU) of patients and signs of urethral inflammation. The strongest association was between detecting M genitalium in FVU and number of PMNLs in urethral smears (n = 6790; OR 2.1; 95 % CI 1.5 to 2.9). The association was less significant between detecting M genitalium in cervical swabs and the number of PMNLs in urethral smears (n = 6785; OR 1.4; 95% CI 1.1 to 1.9), although cervical swabs gave higher sensitivity than FVU in detecting M genitalium (86% vs 62%). C trachomatis detection in FVU and cervical swabs was highly concordant and both significantly associated with urethritis (n = 6790; OR 3.6; 95% CI 3.0 to 4.4).


CONCLUSIONS
This data support the hypothesis that M genitalium causes urethritis in women and that M genitalium infection of the genitourinary tract leads to different clinical manifestations depending on whether the site of infection is the urethral or the cervical epithelium.
Moi
H
H
Olafia, Medical Division, Rikshospitalet University Hospital and University of Oslo, Medical Faculty, Oslo, Norway.
Reinton
N
N
Moghaddam
A
A
D000328:Adult; D005260:Female; D006801:Humans; D009175:Mycoplasma Infections / Q000453:epidemiology* / Q000382:microbiology; D045704:Mycoplasma genitalium / Q000302:isolation & purification*; D009664:Norway / Q000453:epidemiology; D009812:Odorants; D015995:Prevalence; D012680:Sensitivity and Specificity; D014526:Urethritis / Q000453:epidemiology* / Q000382:microbiology; D002575:Uterine Cervicitis / Q000453:epidemiology* / Q000382:microbiology; D014626:Vaginal Smears / Q000706:statistics & numerical data; D016585:Vaginosis, Bacterial / Q000453:epidemiology / Q000382:microbiology